ALTSHULER DAVID (EVP, Global Research and CSO) sold 9.8% of their position (3.23K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.58M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2025ACC: 0000875320-25-000139
Officer· EVP, Global Research and CSO
Since Jun 2018
-3.23K
Net shares
Net seller
$1.58M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.23K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.23K
Price / share
$490.00
Trade value
$1.58M
% of position
9.8%
3/3/2025
32.97K→29.74K
Total
Net shares
−3.23K
Net value
-$1.58M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2025 | S · Sale | −3.23K | $490.00 | $1.58M | 9.8% | 32.97K | 29.74K |
| Total | −3.23K | -$1.58M | ||||||
Derivative Transactions0
No derivative transactions reported